antiretroviral therapy rollout
Recently Published Documents


TOTAL DOCUMENTS

9
(FIVE YEARS 0)

H-INDEX

6
(FIVE YEARS 0)

2012 ◽  
Vol 2012 ◽  
pp. 1-5 ◽  
Author(s):  
Theresa T. Liu ◽  
Douglas Wilson ◽  
Halima Dawood ◽  
D. William Cameron ◽  
Gonzalo G. Alvarez

Despite the South African antiretroviral therapy rollout, which should reduce the incidence of HIV-associated tuberculosis (TB), the number of TB-attributable deaths in KwaZuluNatal (KZN) remains high. TB is often diagnosed clinically, without microbiologic confirmation, leading to inaccurate estimates of TB-attributed deaths. This may contribute to avoidable deaths, and impact population-based TB mortality estimates.Objectives. (1) To measure the number of cases with microbiologically confirmed TB in a retrospective cohort of deceased inpatients with TB-attributed hospital deaths. (2) To estimate the rates of multi-drug resistant (MDR) and extensively drug resistant (XDR) TB in this cohort.Results. Of 2752 deaths at EDH between September 2006 and March 2007, 403 (15%) were attributed to TB on the death certificate. 176 of the TB-attributed deaths (44%) had a specimen sent for smear or culture; only 64 (36%) had a TB diagnosis confirmed by either test. Of the 39 culture-confirmed cases, 27/39 (69%) had fully susceptible TB and 27/39 (69%) had smear-negative culture-positive TB (SNTB). Two patients had drug monoresistance, three patients had MDR-TB, and one had XDR-TB.Conclusions. Most TB-attributed deaths in this cohort were not microbiologically confirmed. Of confirmed cases, most were smear-negative, culture positive and were susceptible to all first line drugs.


AIDS ◽  
2004 ◽  
Vol 18 (15) ◽  
pp. 2105-2106 ◽  
Author(s):  
Jonathan Cohen ◽  
Sylvestor Kimaiyo ◽  
Winstone Nyandiko ◽  
Abraham Siika ◽  
John Sidle ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document